Stock Price Quote

JAGSONPAL PHARMACEUTICALS LTD.

NSE : JAGSNPHARMBSE : 507789ISIN CODE : INE048B01027Industry : Pharmaceuticals & DrugsHouse : Jagsonpal
BSE146.5524.4 (+19.98 %)
PREV CLOSE ( ) 122.15
OPEN PRICE ( ) 122.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 174603
TODAY'S LOW / HIGH ( )122.00 146.55
52 WK LOW / HIGH ( )26.4 146.55
NSE146.4524.4 (+19.99 %)
PREV CLOSE( ) 122.05
OPEN PRICE ( ) 121.45
BID PRICE (QTY) 146.45 (65066)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1173901
TODAY'S LOW / HIGH( ) 121.45 146.45
52 WK LOW / HIGH ( )25.2 146.45
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1978
Management Info
R P S Kochhar - Chairman R P S Kochhar - Managing Director
Registered Office

Address T 210 J,Shabpur Jat, ,
New Delhi,
Delhi-110049

Phone 011-46181100 & 46119900

Email nandita.singh@jagsonpal.com

Website www.jagsonpal.com

Registrars Details
MCS Ltd
F-65, ,Okhla Industrial Area,Phase - I,New Delhi
Listing : BSE, NSE, MCX

NEWS

17May Board Meeting Intimation for Investme
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the B..
26Apr Clarification sought from Jagsonpal P
The Exchange has sought clarification from Jagsonpal Pharmaceuticals Ltd..
28Oct Jagsonpal Pharmaceuticals informs abou
In terms of sub-regulation 9 & 10 of Regulation 40 of SEBI of (Listi..
01Jul Jagsonpal Pharmaceuticals informs abou
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosu..
13Feb Jagsonpal Pharmaceuticals informs abou
Jagsonpal Pharmaceuticals has informed that the Board of Directors of th..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit54.3278.6999999999999
Gross Profit 66.09 94.1399999999999
Operating Profit 70.18110.58
Net Sales 571.041585.68

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  16323.30 (1.37%)
M.Cap ( in Cr)34685.87
Dr. Reddys Lab (BSE)
peergroup  5451.20 (3.03%)
M.Cap ( in Cr)90677.61
Alkem Laboratories (BSE)
peergroup  3195.75 (2.11%)
M.Cap ( in Cr)38209.98
Piramal Enterprises (BSE)
peergroup  2252.60 (2.66%)
M.Cap ( in Cr)50804.76
Caplin Point Lab (BSE)
peergroup  663.80 (7.98%)
M.Cap ( in Cr)5021.17

Shareholding Pattern

PROMOTERS 70.34%
NON-INSTITUTION 29.65%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
MUTUAL FUNDS/UTI 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
Taurus Flexi Cap Fu...0.11

About Jagsonpal Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals Ltd. was incorporated in the year 1978. Its today's share price is 146.55. Its current market capitalisation stands at Rs 383.93 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1585.68 Cr and Total Income of Rs.1610.94 Cr. The company's management includes Nandita Singh, Mammen Mathew, Ashok Kumar Pati, Ishpal Singh Ghai, Bharat Sinh, Jasbir Kaur Kochhar, R P S Kochhar, R P S Kochhar.

It is listed on the BSE with a BSE Code of 507789 , NSE with an NSE Symbol of JAGSNPHARM and ISIN of INE048B01027. It's Registered office is at T 210 J,Shabpur Jat, New Delhi-110049, Delhi. Their Registrars are ACC Ltd. It's auditors are HL Bansal & Co, PP Thukral & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)